As a global leader in CDMO services, Asymchem delivers comprehensive, one-stop solutions across the pharmaceutical value chain for over 25 years. 

Built on a strong foundation in small molecule CDMO services, the company has established mature capabilities in TIDES, biologics, drug product services, clinical research services, synthetic biology, and technology transfer. Asymchem’s commitment to excellence is reflected in its robust global presence, spanning R&D and manufacturing facilities in China, the United States, United Kingdom, and beyond, with a team of over 9,000 professionals, 45% of whom are dedicated to R&D.

Trusted by global pharma and biotech leaders, Asymchem adheres to the highest cGMP and EHS standards and delivers high-quality, cost-effective services, reducing time-to-market for therapies and providing client-centric solutions to meet the diverse needs of global drug development.